Suppr超能文献

铁转运蛋白多聚体结构的证据。

Evidence for the multimeric structure of ferroportin.

作者信息

De Domenico Ivana, Ward Diane McVey, Musci Giovanni, Kaplan Jerry

机构信息

Department of Pathology, School of Medicine, University of Utah, Salt Lake City, UT 84132, USA.

出版信息

Blood. 2007 Mar 1;109(5):2205-9. doi: 10.1182/blood-2006-06-032516. Epub 2006 Oct 31.

Abstract

Ferroportin (Fpn) (IREG1, SLC40A1, MTP1) is an iron transporter, and mutations in Fpn result in a genetically dominant form of iron overload disease. Previously, we demonstrated that Fpn is a multimer and that mutations in Fpn are dominant negative. Other studies have suggested that Fpn is not a multimer and that overexpression or epitope tags might affect the localization, topology, or multimerization of Fpn. We generated wild-type Fpn with 3 different epitopes, GFP, FLAG, and c-myc, and expressed these constructs in cultured cells. Co-expression of any 2 different epitope-tagged proteins in the same cell resulted in their quantitative coimmunoprecipitation. Treatment of Fpn-GFP/Fpn-FLAG-expressing cells with crosslinking reagents resulted in the crosslinking of Fpn-GFP and Fpn-FLAG. Western analysis of rat glioma C6 cells or mouse bone marrow macrophages exposed to crosslinking reagents showed that endogenous Fpn is a dimer. These results support the hypothesis that the dominant inheritance of Fpn-iron overload disease is due to the dominant-negative effects of mutant Fpn proteins.

摘要

铁转运蛋白(Fpn)(IREG1、SLC40A1、MTP1)是一种铁转运体,Fpn的突变会导致一种遗传性显性形式的铁过载疾病。此前,我们证明Fpn是一种多聚体,且Fpn中的突变具有显性负效应。其他研究表明Fpn不是多聚体,过表达或表位标签可能会影响Fpn的定位、拓扑结构或多聚化。我们构建了带有3种不同表位(绿色荧光蛋白、FLAG和c-myc)的野生型Fpn,并在培养细胞中表达这些构建体。在同一细胞中共表达任意两种不同表位标记的蛋白会导致它们定量共免疫沉淀。用交联剂处理表达Fpn-GFP/Fpn-FLAG的细胞会导致Fpn-GFP和Fpn-FLAG交联。对暴露于交联剂的大鼠胶质瘤C6细胞或小鼠骨髓巨噬细胞进行蛋白质印迹分析表明,内源性Fpn是二聚体。这些结果支持以下假说:Fpn铁过载疾病的显性遗传是由于突变Fpn蛋白的显性负效应。

相似文献

1
Evidence for the multimeric structure of ferroportin.
Blood. 2007 Mar 1;109(5):2205-9. doi: 10.1182/blood-2006-06-032516. Epub 2006 Oct 31.
2
The molecular basis of ferroportin-linked hemochromatosis.
Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8955-60. doi: 10.1073/pnas.0503804102. Epub 2005 Jun 13.
3
The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.
Blood. 2007 May 15;109(10):4174-80. doi: 10.1182/blood-2007-01-066068. Epub 2007 Feb 8.
5
Wild-type and mutant ferroportins do not form oligomers in transfected cells.
Biochem J. 2006 Jun 1;396(2):265-75. doi: 10.1042/BJ20051682.
6
Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
Blood. 2018 Feb 22;131(8):899-910. doi: 10.1182/blood-2017-05-786590. Epub 2017 Dec 13.
7
Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Hum Mutat. 2013 Nov;34(11):1529-36. doi: 10.1002/humu.22396. Epub 2013 Sep 11.
8
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations.
Blood. 2005 May 15;105(10):4096-102. doi: 10.1182/blood-2004-11-4502. Epub 2005 Feb 3.
9
A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation).
Biochem Biophys Rep. 2021 Jan 8;25:100873. doi: 10.1016/j.bbrep.2020.100873. eCollection 2021 Mar.

引用本文的文献

1
The Ferroxidase-Permease System for Transport of Iron Across Membranes: From Yeast to Humans.
Int J Mol Sci. 2025 Jan 21;26(3):875. doi: 10.3390/ijms26030875.
3
Role of a Tyrosine Radical in Human Ceruloplasmin Catalysis.
ACS Cent Sci. 2020 Oct 28;6(10):1835-1843. doi: 10.1021/acscentsci.0c00953. Epub 2020 Sep 2.
5
New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich's Ataxia Patient.
Oxid Med Cell Longev. 2019 Mar 27;2019:7623023. doi: 10.1155/2019/7623023. eCollection 2019.
6
Intersection of Iron and Copper Metabolism in the Mammalian Intestine and Liver.
Compr Physiol. 2018 Sep 14;8(4):1433-1461. doi: 10.1002/cphy.c170045.
7
Ferroportin disease: pathogenesis, diagnosis and treatment.
Haematologica. 2017 Dec;102(12):1972-1984. doi: 10.3324/haematol.2017.170720. Epub 2017 Nov 3.
8
Hamp1 but not Hamp2 regulates ferroportin in fish with two functionally distinct hepcidin types.
Sci Rep. 2017 Nov 1;7(1):14793. doi: 10.1038/s41598-017-14933-5.
9
Human macrophage ferroportin biology and the basis for the ferroportin disease.
Hepatology. 2017 May;65(5):1512-1525. doi: 10.1002/hep.29007. Epub 2017 Mar 22.
10
Ironing out Ferroportin.
Cell Metab. 2015 Nov 3;22(5):777-87. doi: 10.1016/j.cmet.2015.09.006. Epub 2015 Oct 1.

本文引用的文献

2
Wild-type and mutant ferroportins do not form oligomers in transfected cells.
Biochem J. 2006 Jun 1;396(2):265-75. doi: 10.1042/BJ20051682.
3
Impaired iron transport activity of ferroportin 1 in hereditary iron overload.
J Membr Biol. 2005 Jul;206(1):3-7. doi: 10.1007/s00232-005-0768-1.
4
Iron imports. IV. Hepcidin and regulation of body iron metabolism.
Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G199-203. doi: 10.1152/ajpgi.00412.2005.
5
Ferroportin is a monomer in vivo in mice.
Blood Cells Mol Dis. 2006 Jan-Feb;36(1):26-32. doi: 10.1016/j.bcmd.2005.11.001. Epub 2005 Dec 27.
6
Non-HFE hemochromatosis.
Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316.
8
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.
Cell Metab. 2005 Mar;1(3):191-200. doi: 10.1016/j.cmet.2005.01.003.
9
The molecular basis of ferroportin-linked hemochromatosis.
Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8955-60. doi: 10.1073/pnas.0503804102. Epub 2005 Jun 13.
10
Functional consequences of ferroportin 1 mutations.
Blood Cells Mol Dis. 2005 Jul-Aug;35(1):33-46. doi: 10.1016/j.bcmd.2005.04.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验